Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Radius Raises $91 Million, Moves Toward Public Listing

01 Jun 2011

• By Paul Bonanos

Related Content

Amgen Shifts Its Focus From Products To Pipeline, But Stays In Comfort Zone

02 May 2011

Shire Nabs Advanced BioHealing Before It Can Test the Public Waters

17 May 2011

MPM/Novartis Fund Deals with Radius

01 Oct 2007

Related Companies

Radius Health, Inc.

Ipsen SA

Novartis AG

Johnson & Johnson

Takeda Pharmaceutical Co. Ltd.

Takeda Pharmaceutical Co. Ltd.

Eli Lilly and Company

Roche Holding AG

GSK plc

Amgen, Inc.

3M

3M

Additional Topics

Business Strategies BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.